Amanda Hahn

PhD student at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Gustav Ullenhag

E-mail:: amanda.hahn@igp.uu.se
Visiting address:: Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Postal address:: Akademiska sjukhuset, ingång 100/101
751 85 Uppsala

Download contact information for Amanda Hahn at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Gustav Ullenhag

Publications

Recent publications

First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies

Carneiro, Ana; Hahn, Amanda; Ellmark, Peter; Enell Smith, Karin et al.

Part of Journal for ImmunoTherapy of Cancer, 2025
- DOI for First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
- Download full text (pdf) of First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies

All publications

Articles in journal

First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies

Carneiro, Ana; Hahn, Amanda; Ellmark, Peter; Enell Smith, Karin et al.

Part of Journal for ImmunoTherapy of Cancer, 2025
- DOI for First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
- Download full text (pdf) of First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies